Literature DB >> 6087053

Anterior hypotympanic approach for glomus tumor of the infratemporal fossa.

J B Farrior.   

Abstract

The anterior hypotympanic approach to the infratemporal fossa permits direct exposure of glomus jugulare and glomus tympanicum tumors of the middle ear, hypotympanum and petrous apex with the preservation of normal structures and hearing. Smaller glomus tumors arising in the middle ear extend anteriorly along the paths of least resistance into the hypotympanum and petrous apex to involve the carotid canal and, only later in the course of disease, extensively involve the jugular bulb, neck, or mastoid air cell system. Clinical experience demonstrates that this approach can effectively cure or control small glomus tumors in selected patients. In patients with more extensive disease, the surgical field may be expanded by removing the mastoid tip with facial nerve mobilization to remove the jugular bulb and posterior tumor extensions while preserving middle ear function and hearing.

Entities:  

Mesh:

Year:  1984        PMID: 6087053     DOI: 10.1288/00005537-198408000-00004

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Transmastoid-infralabyrinthine tailored surgery of jugular paragangliomas.

Authors:  Mislav Gjuric; Mario Bilic
Journal:  Skull Base       Date:  2009-01

2.  Comparative results of infratemporal fossa approach with or without facial nerve rerouting in jugular fossa tumors.

Authors:  J L Llorente; S Obeso; F López; J C Rial; A Coca; C Suárez
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-07-24       Impact factor: 2.503

3.  [Gradenigo syndrome--still a threatening complication of otitis media].

Authors:  M Bloching; C Heider; S Amm; S Kösling
Journal:  HNO       Date:  2005-10       Impact factor: 1.284

4.  Less invasive transjugular approach with Fallopian bridge technique for facial nerve protection and hearing preservation in surgery of glomus jugulare tumors.

Authors:  Yoichi Nonaka; Takanori Fukushima; Kentaro Watanabe; Allan H Friedman; John T McElveen; Calhoun D Cunningham; Ali R Zomorodi
Journal:  Neurosurg Rev       Date:  2013-06-06       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.